432 related articles for article (PubMed ID: 10558582)
1. Quality mammography standards. Department of Health and Human Services (HHS), Public Health Service (PHS), Food and Drug Administration (FDA). Direct final rule.
Fed Regist; 1999 Jun; 64(116):32404-7. PubMed ID: 10558582
[TBL] [Abstract][Full Text] [Related]
2. Amendment of various device regulations to reflect current American Society for Testing and Material citations. Food and Drug Administration, HHS. Direct final rule.
Fed Regist; 2000 Jan; 65(15):3584-5. PubMed ID: 11010654
[TBL] [Abstract][Full Text] [Related]
3. Medical devices; humanitarian use of devices--FDA. Direct final rule.
Fed Regist; 1998 Apr; 63(74):19185-90. PubMed ID: 10178430
[TBL] [Abstract][Full Text] [Related]
4. Medical devices; establishment registration and device listing for manufacturers and distributors of devices--FDA. Direct final rule.
Fed Regist; 1998 Sep; 63(188):51825-7. PubMed ID: 10185812
[TBL] [Abstract][Full Text] [Related]
5. Medical device reporting: manufacturer reporting, importer reporting, user facility reporting, and distributor reporting--FDA. Direct final rule.
Fed Regist; 1998 May; 63(91):26069-77. PubMed ID: 10179334
[TBL] [Abstract][Full Text] [Related]
6. Medical devices; reports of corrections and removals--FDA. Direct final rule.
Fed Regist; 1998 Aug; 63(152):42229-33. PubMed ID: 10181725
[TBL] [Abstract][Full Text] [Related]
7. Medical devices; 30-day notices and 135-day PMA (premarket approval application) supplement review--FDA. Direct final rule.
Fed Regist; 1998 Apr; 63(80 Pt 1):20530-3. PubMed ID: 10179319
[TBL] [Abstract][Full Text] [Related]
8. Amendment to examination and investigation sample requirements--FDA. Direct final rule.
Fed Regist; 1998 Sep; 63(186):51297-9. PubMed ID: 10185810
[TBL] [Abstract][Full Text] [Related]
9. Removal of regulations regarding certification of drugs composed wholly or partly of insulin--FDA. Direct final rule.
Fed Regist; 1998 May; 63(92):26694-9. PubMed ID: 10179341
[TBL] [Abstract][Full Text] [Related]
10. Medical devices; hearing aids; technical data amendments. Direct final rule.
Food and Drug Administration, HHS
Fed Regist; 2008 Jun; 73(106):31358-60. PubMed ID: 18677822
[TBL] [Abstract][Full Text] [Related]
11. Investigational new drug applications; clinical holds--FDA. Direct final rule.
Fed Regist; 1998 Dec; 63(239):68676-8. PubMed ID: 10187558
[TBL] [Abstract][Full Text] [Related]
12. Amendment to the current good manufacturing practice regulations for finished pharmaceuticals. Direct final rule.
Food and Drug Administration, HHS
Fed Regist; 2007 Dec; 72(232):68064-70. PubMed ID: 18064770
[TBL] [Abstract][Full Text] [Related]
13. Revisions to the requirements applicable to blood, blood components, and source plasma. Department of Health and Human Services (HHS), Public Health Service (PHS), Food and Drug Administration (FDA). Direct final rule.
Fed Regist; 1999 Aug; 64(160):45366-74. PubMed ID: 10558597
[TBL] [Abstract][Full Text] [Related]
14. Amendments to general regulations of the Food and Drug Administration. Direct final rule.
Food and Drug Administration, HHS
Fed Regist; 2010 Nov; 75(229):73951-5. PubMed ID: 21121182
[TBL] [Abstract][Full Text] [Related]
15. Revisions to the general safety requirements for biological products--FD. Direct final rule.
Fed Regist; 1998 Apr; 63(75):19399-403. PubMed ID: 10178869
[TBL] [Abstract][Full Text] [Related]
16. Medical devices; medical device reporting; baseline reports. Direct final rule.
Food and Drug Administration, HHS
Fed Regist; 2008 Jun; 73(115):33692-5. PubMed ID: 18677824
[TBL] [Abstract][Full Text] [Related]
17. Medical devices; medical device reporting. Direct final rule.
Food and Drug Administration, HHS
Fed Regist; 2005 Feb; 70(38):9516-28. PubMed ID: 15736310
[TBL] [Abstract][Full Text] [Related]
18. Revision of requirements applicable to albumin (human), plasma protein fraction (human), and immune globulin (human). Food and Drug Administration, HHS. Direct final rule.
Fed Regist; 1999 May; 64(93):26282-7. PubMed ID: 10558530
[TBL] [Abstract][Full Text] [Related]
19. Revision to requirements for licensed Anti-Human Globulin and Blood Grouping Reagents. Food and Drug Administration, HHS. Direct final rule.
Fed Regist; 2000 Dec; 65(239):77497-9. PubMed ID: 11503726
[TBL] [Abstract][Full Text] [Related]
20. Current good manufacturing practice regulation and investigational new drugs. Direct final rule.
Food and Drug Administration. HHS
Fed Regist; 2006 Jan; 71(10):2458-62. PubMed ID: 16479693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
